RUA Life Sciences (AOHA) AI Stock Analysis

RUA Life Sciences

(Frankfurt:AOHA)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Specialized biomaterials platformThe company operates across biomaterials supply, product development support, and manufacturing for medical-device customers. This integrated capability can deepen customer relationships and support recurring demand when development programs progress into regulated commercial production.

Negative Factors

Operating losses persistOperating profitability has not yet been established, so strong gross margin is not currently translating into sustainable earnings after operating costs. Continued EBIT losses could restrict internal funding, delay shareholder returns, and leave results sensitive to the timing of customer-program progress.

RUA Life Sciences (AOHA) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 17.69M
Dividend Yield: ―
Average Volume (3M): 550
Price to Earnings (P/E): -123.9
Beta (1Y): 0.55
Revenue Growth: ―
EPS Growth: ―
Country: Germany
Employees: 59
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

RUA Life Sciences Business Overview & Revenue Model

Company Description

RUA Life Sciences plc, operating with its subsidiaries, delivers specialized polymers, various services, and finished products to the global medical device sector, spanning Europe, the United States, and other international markets. The company's ope...

RUA Life Sciences Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:AOHA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:GDR	49Neutral	GBP 15.65M	-0.89	-1044.57%	―	65.60%	74.84%
GB:IHC	48Neutral	GBP 15.47M	-25.37	-3.85%	―	0.88%	94.67%
GB:OPTI	41Neutral	GBP 5.99M	-1.40	-77.85%	―	11.90%	-2864.29%
GB:CREO	40Underperform	GBP 51.09M	-2.51	-38.29%	―	―	―
GB:SUN	40Underperform	GBP 3.73M	-4.00	-15.47%	―	-3.68%	20.00%

* Healthcare Sector Average

Performance Comparison

DE:AOHA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:AOHA	Rua Life Sciences Plc	0.30	0.20	211.34%
GB:CREO	Creo Medical	11.38	0.13	1.11%
GB:GDR	Genedrive plc	0.97	0.01	1.25%
GB:IHC	Inspiration Healthcare	17.25	-3.00	-14.81%
GB:OPTI	OptiBiotix Health	5.80	-2.20	-27.50%
GB:SUN	Surgical Innovations Group Plc	0.40	-0.18	-31.03%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

RUA Life Sciences AI Stock Analysis